NexTel Medical Corp. has announced a joint venture to commercialize and scale a patented hair regeneration formula. Targeting the rapidly growing hair restoration market, the non-invasive technology is designed to stimulate dormant hair follicles while strengthening and thickening existing hair, offering a potential alternative to microneedling. The partners also plan to seek additional patent protection for the delivery platform, with commercial launch targeted for Q4 2026. The agreement marks a step toward expanding NexTel’s commercial presence in technology-driven hair restoration.